Trademark: 86839634
Word
RYLEVO
Status
Dead
Status Code
710
Status Date
Friday, January 27, 2023
Serial Number
86839634
Registration Number
4998214
Registration Date
Tuesday, July 12, 2016
Mark Type
4000
Filing Date
Friday, December 4, 2015
Published for Opposition
Tuesday, April 26, 2016
Cancellation Date
Friday, January 27, 2023

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Jan 27, 2023
Cancelled Sec. 8 (6-Yr)
Nov 8, 2022
Teas Change Of Correspondence Received
Nov 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 12, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 12, 2016
Registered-Principal Register
Apr 26, 2016
Official Gazette Publication Confirmation E-Mailed
Apr 26, 2016
Published For Opposition
Apr 6, 2016
Notification Of Notice Of Publication E-Mailed
Mar 14, 2016
Approved For Pub - Principal Register
Mar 11, 2016
Assigned To Examiner
Dec 9, 2015
New Application Office Supplied Data Entered
Dec 8, 2015
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24